New study probes why some babies develop eczema: Self-Antibodies under the microscope

NCT ID NCT07316465

Recruiting now Knowledge-focused Sponsor: Universitair Ziekenhuis Brussel Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether babies born with certain self-reactive antibodies are more likely to develop eczema. Researchers will test umbilical cord blood from 500 newborns—some with a family history of allergies or eczema, some without—and follow them for two years. The goal is to understand when and why these antibodies appear and if they can predict eczema.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

allergic disease atopic eczema autoimmune disease Hypersensitivity, Immediate

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALLERGIC DISEASE ATOPIC DERMATITIS (AD) AUTO-IMMUNITY AUTOANTIBODY IGE-MEDIATED HYPERSENSITIVITY MICROBIOME, HUMAN NEWBORN, INFANT

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Universitair Ziekenhuis (UZ) Brussel, Vrije Universiteit Brussel (VUB)
RECRUITING

Jette, Brussels Capital, 1090, Belgium

Contact Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••